3-year, Open-Label Study Evaluating Safety, Tolerability, and Efficacy of Lorecivivint in Knee Osteoarthritis

NCT04931667 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
72
Enrollment
INDUSTRY
Sponsor class

Stopped Study was terminated by Sponsor based on a business decision not due to safety. The study report was finalized without any statistical analysis.

Conditions

Interventions

Sponsor

Biosplice Therapeutics, Inc.